Efficacy and safety of empagliflozin for type 2 diabetes mellitus: Meta-analysis of randomized controlled trials

BACKGROUND: This study was designed to evaluate the efficiency and tolerability of empagliflozin (EMPA) as monotherapy or add-on to existing therapy in patients with type 2 diabetes mellitus (T2DM). METHODS: Randomized controlled trials (RCTs) comparing efficacy and safety of EMPA vs placebo or EMPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun-Jing, Han, Shi-Liang, Sun, Xi-Feng, Wang, Shu-Xiang, Wang, Hong-Yun, Liu, Xiao, Chen, Li, Xia, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221554/
https://www.ncbi.nlm.nih.gov/pubmed/30412076
http://dx.doi.org/10.1097/MD.0000000000012843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221554/
https://www.ncbi.nlm.nih.gov/pubmed/30412076
http://dx.doi.org/10.1097/MD.0000000000012843

Ejemplares similares